Is the price fair?
What RDNT's price assumes
Today's price asks for 20% free cash flow growth a year; over the last three years RadNet, Inc. delivered 23%, less than the record.
2.01
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 1.7%
Free cash flow yield · Diagnostics & Research median 4.2%
- Growth the price implies
- +20%
Growth the price implies · The price pays for +20% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.
- Price / book
- 3.99
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 3.99
- EV / EBIT2026-Q1
- 79.4
- EV / sales2026-Q1
- 2.30
- Free cash flow, trailing twelve months
- $72M
- Market capitalisation
- $4.23B
- 3-year revenue growth
- +14%
- 3-year free cash flow growth
- +23%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #5 of 29 by Smart Score